Here's a little more about those well publicized cancer vaccines. They have their pluses and minuses which are clearly illustrated in these two diagrams:
Many more cancer vaccines are under development, with hundreds of
trials underway in patients with breast, prostate, lung, kidney, colon,
cervical, brain, and pancreatic cancers, as well as lymphomas. Once
companies confirm the effectiveness of these therapies in one type of
cancer, they are likely to try them in others.
“From the immune point of view, the distinction between one cancer
type and the next is not so important,’’ said Dranoff, who did early
work on Yervoy. “That’s part of why so many companies now are developing
So a lot more promise but we need to be patient. Crap. I am sick of being a patient patient. But I will suck it up and continue to optimistically watch this progress.